Interferon beta-1b biosimilar (Biocad)

干扰素β-1b生物类似药 (Biocad)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta-1b biosimilar (Biocad)

Drug Alias Name干扰素β-1b生物仿制药 (Biocad)Recombinant human interferon beta-1b biosimilar (Biocad)重组人干扰素β-1b生物仿制药 (Biocad)Ronbetal

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBIOCAD JSC

China Registration ClassN/A

Active CompaniesBIOCAD JSC

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsN/A

ATC CodeL03AB08